Peak Expiratory Flow Rate
"Peak Expiratory Flow Rate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR.
Descriptor ID |
D010366
|
MeSH Number(s) |
E01.370.386.700.660.225.600 G09.772.650.300.790
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peak Expiratory Flow Rate".
Below are MeSH descriptors whose meaning is more specific than "Peak Expiratory Flow Rate".
This graph shows the total number of publications written about "Peak Expiratory Flow Rate" by people in this website by year, and whether "Peak Expiratory Flow Rate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 1 | 2 |
2004 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peak Expiratory Flow Rate" by people in Profiles.
-
Eichaker L, Li C, King N, Pepper V, Best C, Onwuka E, Heuer E, Zhao K, Grischkan J, Breuer C, Johnson J, Chiang T. Quantification of tissue-engineered trachea performance with computational fluid dynamics. Laryngoscope. 2018 08; 128(8):E272-E279.
-
Martinez FJ, Mannino D, Leidy NK, Malley KG, Bacci ED, Barr RG, Bowler RP, Han MK, Houfek JF, Make B, Meldrum CA, Rennard S, Thomashow B, Walsh J, Yawn BP. A New Approach for Identifying Patients with Undiagnosed Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2017 03 15; 195(6):748-756.
-
Nelson SB, LaVange LM, Nie Y, Walsh JW, Enright PL, Martinez FJ, Mannino DM, Thomashow BM. Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012 Aug; 142(2):358-366.
-
Bolen AR, Henneberger PK, Liang X, Sama SR, Preusse PA, Rosiello RA, Milton DK. The validation of work-related self-reported asthma exacerbation. Occup Environ Med. 2007 May; 64(5):343-8.
-
Tateno H, Nakamura H, Minematsu N, Nakajima T, Takahashi S, Nakamura M, Fukunaga K, Asano K, Lilly CM, Yamaguchi K. Plasma eotaxin level and severity of asthma treated with corticosteroid. Respir Med. 2004 Aug; 98(8):782-90.
-
Chanez P, Karlstrom R, Godard P. High or standard initial dose of budesonide to control mild-to-moderate asthma? Eur Respir J. 2001 May; 17(5):856-62.
-
Kriebel D, Myers D, Cheng M, Woskie S, Cocanour B. Short-term effects of formaldehyde on peak expiratory flow and irritant symptoms. Arch Environ Health. 2001 Jan-Feb; 56(1):11-8.
-
Delfino RJ, Zeiger RS, Seltzer JM, Street DH, Matteucci RM, Anderson PR, Koutrakis P. The effect of outdoor fungal spore concentrations on daily asthma severity. Environ Health Perspect. 1997 Jun; 105(6):622-35.
-
Eisen EA, Wegman DH, Kriebel D, Woskie SR, Hu X. An epidemiologic approach to the study of acute reversible health effects in the workplace. Epidemiology. 1991 Jul; 2(4):263-70.